As the NHS financial year draws to an end we bring together our esteemed panel of NHS commentators with specific expertise in rare diseases to help you interpret the strategic and tactical changes within the NHS and its likely impact on industry.
This timely 60-minute masterclass for LSAA members will help YOU enhance patient outcomes during 2024 and beyond.
8th Mar 2024 13:00 – 14:00 (GMT)
Speakers
Owner & Lead Consultant at Sagio Ltd
Managing Director of Oxygen Strategy
Principal, Head of Market Access - IQVIA
Chief Executive Officer - Initiate
Member of the Board of Advisors - ATMPS | Consultant - CSL Behring UK